JP2021524248A5 - - Google Patents

Info

Publication number
JP2021524248A5
JP2021524248A5 JP2020565274A JP2020565274A JP2021524248A5 JP 2021524248 A5 JP2021524248 A5 JP 2021524248A5 JP 2020565274 A JP2020565274 A JP 2020565274A JP 2020565274 A JP2020565274 A JP 2020565274A JP 2021524248 A5 JP2021524248 A5 JP 2021524248A5
Authority
JP
Japan
Prior art keywords
cells
chimeric antigen
receptor
amino acid
antigen receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020565274A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021524248A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/AU2019/050487 external-priority patent/WO2019222796A1/en
Publication of JP2021524248A publication Critical patent/JP2021524248A/ja
Publication of JP2021524248A5 publication Critical patent/JP2021524248A5/ja
Pending legal-status Critical Current

Links

JP2020565274A 2018-05-21 2019-05-20 修飾されたリンカードメインを有するキメラ抗原受容体およびその使用 Pending JP2021524248A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2018901782A AU2018901782A0 (en) 2018-05-21 Chimeric Antigen Receptors with Modified Linker Domain and uses thereof
AU2018901782 2018-05-21
PCT/AU2019/050487 WO2019222796A1 (en) 2018-05-21 2019-05-20 Chimeric antigen receptors with modified linker domains and uses thereof

Publications (2)

Publication Number Publication Date
JP2021524248A JP2021524248A (ja) 2021-09-13
JP2021524248A5 true JP2021524248A5 (cg-RX-API-DMAC7.html) 2022-05-16

Family

ID=68615492

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020565274A Pending JP2021524248A (ja) 2018-05-21 2019-05-20 修飾されたリンカードメインを有するキメラ抗原受容体およびその使用

Country Status (11)

Country Link
US (1) US20220089718A1 (cg-RX-API-DMAC7.html)
EP (1) EP3797164A4 (cg-RX-API-DMAC7.html)
JP (1) JP2021524248A (cg-RX-API-DMAC7.html)
KR (1) KR20210013691A (cg-RX-API-DMAC7.html)
CN (1) CN112166193A (cg-RX-API-DMAC7.html)
AU (1) AU2019275479B2 (cg-RX-API-DMAC7.html)
BR (1) BR112020023489A8 (cg-RX-API-DMAC7.html)
CA (1) CA3099712A1 (cg-RX-API-DMAC7.html)
MX (1) MX2020012445A (cg-RX-API-DMAC7.html)
SG (1) SG11202010451QA (cg-RX-API-DMAC7.html)
WO (1) WO2019222796A1 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12121539B2 (en) 2015-09-11 2024-10-22 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
EP4045648A4 (en) * 2019-10-15 2023-11-22 The Regents of The University of California Transplanted cell protection via fc sequestration
CN111944062B (zh) * 2019-12-09 2023-11-07 深圳市体内生物医药科技有限公司 一种识别Fc片段的嵌合抗原受体及其应用
KR20220140800A (ko) * 2020-02-12 2022-10-18 에스에이비, 엘엘씨 항-흉선세포 글로불린
EP4204005A1 (en) 2020-08-31 2023-07-05 Sab, Llc Ungulate-derived polyclonal immunoglobulin specific for coronavirus protein and uses thereof
CA3211323A1 (en) * 2021-03-11 2022-09-15 Patrick Schlegel Novel cell therapy system
JP2024532482A (ja) * 2021-09-01 2024-09-05 バイオセプター (オースト) プロプライエタリー・リミテッド 免疫活性を刺激するための方法および組成物
EP4476267A4 (en) * 2022-02-11 2026-01-07 Fred Hutchinson Cancer Center CHIMERIC ANTIGENIC RECEPTORS BINDING TO STEAP1
JP2025531675A (ja) * 2022-09-14 2025-09-25 バイオセプター (オースト) プロプライエタリー・リミテッド 操作された免疫細胞の富化
CN120187461A (zh) * 2022-09-14 2025-06-20 生物权威(澳大利亚)有限责任公司 免疫细胞的体内检测
US20260085104A1 (en) * 2022-09-14 2026-03-26 Biosceptre (Aust) Pty Ltd Methods of detecting immune cells
WO2026035817A1 (en) * 2024-08-06 2026-02-12 Board Of Regents, The University Of Texas System Suicide egfr-iii compositions and methods of use thereof

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4579821A (en) 1981-11-23 1986-04-01 University Patents, Inc. Control of DNA sequence transcription
US4601978A (en) 1982-11-24 1986-07-22 The Regents Of The University Of California Mammalian metallothionein promoter system
US4940661A (en) 1984-05-17 1990-07-10 Genentech, Inc. Metallothionein transcription control sequences and use thereof
US5512483A (en) 1993-05-21 1996-04-30 Mcgill University Expression vectors responsive to steroid hormones
US5464758A (en) 1993-06-14 1995-11-07 Gossen; Manfred Tight control of gene expression in eucaryotic cells by tetracycline-responsive promoters
JPH11506319A (ja) 1995-05-26 1999-06-08 ゼネカ・リミテッド エクジソンレセプターを含む遺伝子スイッチ
US5851796A (en) 1995-06-07 1998-12-22 Yale University Autoregulatory tetracycline-regulated system for inducible gene expression in eucaryotes
WO2001020155A1 (fr) * 1999-09-16 2001-03-22 Liangqi Zhang Membrane de reduction de pression pour carburateur
WO2003020762A1 (en) 2001-09-03 2003-03-13 Intreat Pty Limited Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
DK1751181T3 (da) 2004-06-02 2012-11-26 Adalta Pty Ltd BINDINGSDELE, DER ER BASERET PÅ HAJ IgNAR-DOMÆNER
US20100036101A1 (en) 2006-10-10 2010-02-11 Angus Gidley-Baird Antibodies against non functional p2x7 receptor
WO2008043145A1 (en) 2006-10-10 2008-04-17 Biosceptre International Limited Hybridomas producing antibodies against non functional p2x7 receptor
JP5670192B2 (ja) 2007-09-14 2015-02-18 バイオセプター・インターナショナル・リミテッド 新規p2x7エピトープ
AU2009266430B2 (en) 2008-07-04 2014-08-14 Biosceptre International Limited Anti- P2X7 peptides and epitopes
EP3395832B1 (en) 2009-08-20 2021-11-24 Biosceptre (Aust) Pty Ltd Anti p2x7 receptor antibodies and fragments thereof
EP2516470B1 (en) 2009-12-24 2018-02-07 Biosceptre (Aust) Pty Ltd Antibodies to non-functional oligomeric p2x7 receptors
EP3115373B1 (en) * 2010-09-08 2019-08-28 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Chimeric antigen receptors with an optimized hinge region
WO2012073048A2 (en) 2010-12-03 2012-06-07 Cyclogenix Ltd Binding peptides i
ES2688035T3 (es) * 2014-08-29 2018-10-30 Gemoab Monoclonals Gmbh Receptor de antígeno universal que expresa células inmunes para direccionamiento de antígenos múltiples diversos, procedimiento para fabricación del mismo y utilización del mismo para tratamiento de cáncer, infecciones y enfermedades autoinmunes
ES2738705T3 (es) * 2014-09-19 2020-01-24 Hope City Linfocitos T de receptor de antígeno quimérico coestimulante que se dirigen a IL13R 2
CN107429253B (zh) * 2014-12-05 2021-11-05 希望之城公司 Cs1靶向性嵌合抗原受体修饰的t细胞
EP3250611B1 (en) * 2015-01-26 2021-04-21 The University of Chicago Car t-cells recognizing cancer-specific il 13r-alpha2
US12121539B2 (en) * 2015-09-11 2024-10-22 Biosceptre (Aust) Pty Ltd Chimeric antigen receptors and uses thereof
CN114634569B (zh) * 2016-04-15 2024-08-20 达特茅斯大学理事会 高亲和力b7-h6抗体和抗体片段
WO2018017649A1 (en) * 2016-07-19 2018-01-25 Unum Therapeutics Inc. Use of antibody-coupled t cell receptor (actr) with multiple anti-cancer antibodies in cancer treatment
EP3518944A4 (en) * 2016-09-30 2020-06-17 Baylor College of Medicine ADAPTIVE CHIMERIC ANTIGENT RECEPTOR T-CELL DESIGN
EP3315511A1 (en) * 2016-10-29 2018-05-02 Miltenyi Biotec GmbH Adapter chimeric antigen receptor expressing cells for targeting of multiple antigens

Similar Documents

Publication Publication Date Title
US20240228636A1 (en) mAb-DRIVEN CHIMERIC ANTIGEN RECEPTOR SYSTEMS FOR SORTING/DEPLETING ENGINEERED IMMUNE CELLS
JP7797198B2 (ja) ヒトpd-1に対する二機能性分子
CA3122526C (en) Humanized anti-human-pd-1 antibody
JP7807234B2 (ja) 二機能性抗pd-1/il-7分子
JP7675012B2 (ja) 二機能性抗pd-1/sirpa分子
AU2019299439A1 (en) Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereof
CA3111706A1 (en) Chimeric receptor polypeptides in combination with trans metabolism molecules modulating intracellular lactate concentrations and therapeutic uses thereof
KR20240099224A (ko) 항원 결합 폴리펩티드, 항원 결합 폴리펩티드 복합체 및 이의 사용 방법
AU2022288574A1 (en) Multispecific antibodies binding to cd20, nkp46, cd16 and conjugated to il-2
JP7319250B2 (ja) Strep-タグ特異的結合タンパク質およびその使用
BR112017000664B1 (pt) Anticorpo anti-pd-1, combinação de polinucleotídeos isolados, vetor de expressão, e composição farmacêutica
JP2020528765A5 (cg-RX-API-DMAC7.html)
Mohammadi et al. Immunotherapy For Researchers
KR20240005741A (ko) 특성이 향상된 이작용성 분자용 신규한 스캐폴드
JP7558534B2 (ja) Cd137アゴニスト性抗体とその使用
WO2022258678A1 (en) Multispecific proteins binding to nkp30, a cytokine receptor, a tumour antigen and cd16a
WO2022258691A1 (en) Multispecific proteins binding to nkg2d, a cytokine receptor, a tumour antigen and cd16a
US20230002488A1 (en) Guidance and navigation control proteins and method of making and using thereof
JP2026506471A (ja) 組み換えFcドメイン-IL2バリアントポリペプチド及び膜アンカー抗原結合ポリペプチドとの併用療法
US20250101104A1 (en) Bispecific molecule with tunable affinity to a targeted antigen
WO2024028386A1 (en) Multifunctional molecule directed against cd28
CN118252923A (zh) 靶向nkg2d配体的融合蛋白与嵌合抗原受体细胞的组合及其用途
JP2022547650A (ja) ヒトプログラム細胞死受容体pd-1に対する抗体
JP2025530110A (ja) 二重特異性ポリペプチド及びその使用
WO2024238287A1 (en) Dual blocking and chimeric cytokine receptor